Forbes contributors publish independent expert analyses and insights. John Sviokla covers GenAI/AI's impact on commerce and society. This voice experience is generated by AI. Learn more. This voice ...

Ricursive Intelligence, founded by two former Google researchers and valued at $4 billion, is among several efforts to automate the creation of artificial intelligence. Anna Goldie and Azalia ...

Not everyone can declare themselves “benevolent dictator for life” of a company, but such was the nature of Guido van Rossum, the Dutch programmer who invented an entire programming language from ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

Le tribunal administratif de Lyon vient de confirmer la sanction d’exclusion temporaire d’un jour prononcée à l’encontre d’un encadrant de la territoriale à la suite d’altercations avec un subordonné.

Rallybio has swerved away from its Recursion Pharmaceuticals pact, accepting $7.5 million upfront for its share of a preclinical program to extend its cash runway to mid-2027. Exscientia, now part of ...

https://www.riteshmodi.com - Data Scientist, AI and blockchain expert with proven open-source solutions on MLOps, LLMOps and GenAIOps. https://www.riteshmodi.com - Data Scientist, AI and blockchain ...

The results of a recent survey released Tuesday showed President Trump's actions are likely to make it harder for biotech companies like Recursion to raise capital. The company reported ...

AI drug discovery specialist Recursion Pharmaceuticals is shelving three of its most advanced drug prospects in an effort to cut costs following a merger last year. Alongside its latest quarterly ...